Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (197)
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
3,684
Price
$190.22
Total Value
$700.78K
Shares Held After
386,998
% of Holdings
0.9%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
2,469
Price
$106.18
Total Value
$262.16K
Shares Held After
85,533
% of Holdings
2.8%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
5,417
Price
$105.30
Total Value
$570.41K
Shares Held After
88,002
% of Holdings
5.8%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
3,544
Price
$104.39
Total Value
$369.96K
Shares Held After
93,419
% of Holdings
3.7%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
679
Price
$16.00
Total Value
$10.86K
Shares Held After
3,622
% of Holdings
15.8%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
7,479
Price
$16.83
Total Value
$125.84K
Shares Held After
25,318
% of Holdings
22.8%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
500
Price
$15.86
Total Value
$7.93K
Shares Held After
32,797
% of Holdings
1.5%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
6,615
Price
$18.57
Total Value
$122.84K
Shares Held After
166,912
% of Holdings
3.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
3,025
Price
$18.53
Total Value
$56.05K
Shares Held After
166,912
% of Holdings
1.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
1,472
Price
$18.58
Total Value
$27.35K
Shares Held After
166,912
% of Holdings
0.9%
Neuraxis, INC (NRXS)
Henrichs Timothy Robert — Chief Financial Officer
Shares
7,593
Price
$1.96
Total Value
$14.88K
Shares Held After
7,593
% of Holdings
100.0%
Neuraxis, INC (NRXS)
Carrico Thomas Joeseph — CRO, CCO, CPO
Shares
667
Price
$1.96
Total Value
$1.31K
Shares Held After
331,903
% of Holdings
0.2%
Neuraxis, INC (NRXS)
Carrico Brian Allen — Director
Shares
8,060
Price
$1.96
Total Value
$15.80K
Shares Held After
348,178
% of Holdings
2.3%
Erasca, Inc. (ERAS)
Garner Ebun — Chief Legal Officer
Shares
80,000
Price
$16.40
Total Value
$1.31M
Shares Held After
25,076
% of Holdings
76.1%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
3,500
Price
$2.20
Total Value
$7.70K
Shares Held After
29,375
% of Holdings
10.6%
COMPUGEN LTD (CGEN)
Ophir Eran — Director
Shares
5,625
Price
$2.21
Total Value
$12.41K
Shares Held After
11,375
% of Holdings
33.1%
RESMED INC (RMD)
Sandercock Brett — Chief Financial Officer
Shares
1,000
Price
$224.31
Total Value
$224.31K
Shares Held After
83,495
% of Holdings
1.2%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
300
Price
$30.34
Total Value
$9.10K
Shares Held After
12,965
% of Holdings
2.3%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
2,200
Price
$29.32
Total Value
$64.51K
Shares Held After
13,265
% of Holdings
14.2%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
300
Price
$31.07
Total Value
$9.32K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
3,348
Price
$30.06
Total Value
$100.64K
Shares Held After
300
% of Holdings
91.8%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
11,352
Price
$29.24
Total Value
$331.95K
Shares Held After
3,648
% of Holdings
75.7%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
162,517
Price
$3.80
Total Value
$617.40K
Shares Held After
12,794,788
% of Holdings
1.3%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
169,265
Price
$3.80
Total Value
$643.04K
Shares Held After
15,301,237
% of Holdings
1.1%
Hinge Health, Inc. (HNGE)
Mecklenburg Gabriel M.I. — Director
Shares
668
Price
$39.02
Total Value
$26.06K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Mecklenburg Gabriel M.I. — Director
Shares
49,332
Price
$38.45
Total Value
$1.90M
Shares Held After
668
% of Holdings
98.7%
BRISTOL MYERS SQUIBB CO (BMY)
Elkins David V — EVP, Chief Financial Officer
Shares
4,481
Price
$62.05
Total Value
$278.05K
Shares Held After
159,248
% of Holdings
2.7%
BRISTOL MYERS SQUIBB CO (BMY)
Elkins David V — EVP, Chief Financial Officer
Shares
25,519
Price
$61.60
Total Value
$1.57M
Shares Held After
163,729
% of Holdings
13.5%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
2,500
Price
$12.95
Total Value
$32.38K
Shares Held After
119,010
% of Holdings
2.1%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
2,216
Price
$75.95
Total Value
$168.31K
Shares Held After
11,014
% of Holdings
16.7%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
20,105
Price
$75.50
Total Value
$1.52M
Shares Held After
13,230
% of Holdings
60.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
159
Price
$204.26
Total Value
$32.48K
Shares Held After
42,253
% of Holdings
0.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
43
Price
$202.91
Total Value
$8.73K
Shares Held After
42,412
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
79
Price
$202.42
Total Value
$15.99K
Shares Held After
42,455
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
40
Price
$201.24
Total Value
$8.05K
Shares Held After
42,534
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
146
Price
$199.97
Total Value
$29.20K
Shares Held After
42,574
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.45
Total Value
$275.42K
Shares Held After
451,540
% of Holdings
4.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
337
Price
$204.50
Total Value
$68.92K
Shares Held After
41,382
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
963
Price
$203.22
Total Value
$195.70K
Shares Held After
41,719
% of Holdings
2.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
700
Price
$201.90
Total Value
$141.33K
Shares Held After
42,682
% of Holdings
1.6%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,238
Price
$200.94
Total Value
$248.77K
Shares Held After
43,382
% of Holdings
2.8%
Phreesia, Inc. (PHR)
Pale Fire Capital SE — 10% Owner
Shares
168,764
Price
$8.43
Total Value
$1.42M
Shares Held After
8,818,093
% of Holdings
1.9%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,302
Price
$199.72
Total Value
$260.04K
Shares Held After
44,620
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
460
Price
$198.85
Total Value
$91.47K
Shares Held After
45,922
% of Holdings
1.0%
American Well Corp (AMWL)
McNeice Paul Francis — Chief Accounting Officer
Shares
383
Price
$5.30
Total Value
$2.03K
Shares Held After
10,616
% of Holdings
3.5%
American Well Corp (AMWL)
Zamansky Dmitry — Chief Product & Tech. Officer
Shares
5,575
Price
$5.30
Total Value
$29.55K
Shares Held After
241,080
% of Holdings
2.3%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,683
Price
$20.97
Total Value
$98.20K
Shares Held After
80,351
% of Holdings
5.5%
Terns Pharmaceuticals, Inc. (TERN)
Kuriakose Emil — Chief Medical Officer
Shares
942
Price
$52.75
Total Value
$49.69K
Shares Held After
105,673
% of Holdings
0.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,000
Price
$65.71
Total Value
$65.71K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
19,000
Price
$65.36
Total Value
$1.24M
Shares Held After
768,780
% of Holdings
2.4%
Showing 101–150 of 197 transactions (page 3 of 4)